Patent · US Active

PCNA inhibitors

US10550070B2 · kind B2 · utility

3Cited by
5References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 16, 2016
Grant dateFeb 4, 2020
Priority date—
Expiry dateSep 16, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein, inter alia, are compositions of PCNA modulators and methods for treating or preventing cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.